Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic Effects of Colchicine in MI
NCT02995512Phase 4Withdrawn
- Sponsor
- NYU Langone Health
- Start
- May 2017
- Primary completion
- Sep 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
Phase 4, open-label, single-arm trial of colchicine in myocardial infarction (MI), sponsored by NYU Langone Health. Primary endpoint: Number of neutrophils adherent to TNFα-stimulated endothelial cells at 1 Day. Planned start May 2017; status: withdrawn.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02995512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995512.